• BCECF Workflows for Extracellular pH

  2026-09-08

  BCECF converts extracellular acidification into a quantitative dual-excitation ratio, making it useful for ion transport, metabolism, and immune-cell microenvironment studies. This guide shows how to add the probe to efferocytosis experiments without confusing extracellular pH with intracellular dye loading or pathway-specific evidence.

• NF 449: From P2X1 Selectivity to Translation

  2026-09-08

  NF 449 offers translational researchers a way to separate ATP-driven P2X1 signaling from broader platelet responses. This thought-leadership article connects receptor pharmacology, assay design, thrombus biology, and antithrombotic agent research while defining the compound’s limitations and strategic value beyond a conventional product page.

• Xyleborus affinis Fungal Symbionts and Mycangia

  2026-09-07

  Masoudi and colleagues identify a broader fungal consortium in Xyleborus affinis than standard ethanol-based isolation may reveal, including four previously unreported symbionts. By testing individual isolates for colonization of aposymbiotic beetle mycangia, the study provides experimental support for treating all seven recovered fungi as viable mutualistic partners rather than incidental gallery inhabitants.

• Intravesical p21 mRNA-LNP Therapy in Bladder Cancer

  2026-09-07

  The reference study develops chemically modified p21 mRNA packaged in lipid nanoparticles for localized intravesical tumor suppressor replacement. In cell and orthotopic mouse models, this approach restored nuclear p21, altered cell-cycle and DNA-damage markers, suppressed tumor growth, and limited systemic distribution, while leaving important translational questions unresolved.

• 2,2,2-Trichloroethanol for Protein Workflows

  2026-09-05

  Use 2,2,2-Trichloroethanol as a practical in-gel protein analysis reagent for screening electrophoresis conditions, supporting molecular biology research, and improving comparability across protein assays. Its strongest value is as a bench-level complement to, not a replacement for, longitudinal DAT neuroimaging in dopaminergic cell-therapy studies.

• Urolithin A for Mitochondrial and Fibrosis Research

  2026-09-04

  Urolithin A enables a practical bridge between mitochondrial quality-control assays and metabolism-focused hepatic stellate cell studies. This guide outlines solvent handling, dose-and-time screening, orthogonal readouts, and safeguards for testing mitochondrial effects without overstating antifibrotic evidence.

• Sulfo-NHS-LC-Biotin: Practical Labeling Guide

  2026-09-04

  Sulfo-NHS-LC-Biotin is a water-compatible reagent for covalently labeling accessible primary amines on proteins, peptides, and cell-surface proteins for biotin-avidin or streptavidin workflows. It is appropriate for stable extracellular or purified-protein labeling, but not for intracellular or reversible biotinylation.

• Mubritinib–HSA Binding: Methods and Implications

  2026-09-03

  The reference study combines fluorescence spectroscopy, biochemical testing, and molecular docking to define how mubritinib binds human serum albumin (HSA). Its findings connect site I binding and moderate affinity with subtle structural changes and inhibition of HSA esterase-like activity, providing a useful framework for interpreting distribution and protein-mediated effects of mitochondrial electron transport chain inhibitors.

• Protein A/G Magnetic Beads for TNBC IP

  2026-09-03

  Build cleaner IP, RIP, Co-IP, and Ch-IP workflows around the IGF2BP3–FZD1/7 axis in triple-negative breast cancer. These dual-ligand magnetic beads support antibody capture from complex samples while enabling practical controls for protein, RNA, and chromatin readouts.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody Guide

  2026-09-02

  Cy3 Goat Anti-Mouse IgG (H+L) Antibody, SKU K1207, is a Cy3-labeled mouse IgG detection antibody for visualizing mouse primary antibodies in immunofluorescence, flow cytometry, and western blotting. This guide separates product specifications from workflow recommendations and outlines appropriate controls, storage, troubleshooting, and limitations; the reagent is for research use only and is not a diagnostic or medical product.

• Perospirone: A Receptor-to-Channel Assay Framework

  2026-09-02

  Perospirone, also known as SM-9018 free base, offers a useful model for separating high-affinity serotonin–dopamine pharmacology from micromolar vascular Kv-channel effects. This article presents an assay-centered framework for schizophrenia research, neuropsychiatric models, and carefully bounded cardiovascular investigations.

• Roscovitine (Seliciclib): Practical CDK Workflows

  2026-09-01

  Roscovitine (Seliciclib, CYC202) is a reversible, multi-CDK tool for connecting kinase inhibition with late-prophase arrest, washout recovery, and cancer-cell phenotyping. This workflow emphasizes dose design, orthogonal validation, solvent control, and data-driven compound selection rather than treating one phenotype as proof of a single target.

• Thiothixene in Macrophage Efferocytosis Research

  2026-09-01

  Thiothixene is a typical antipsychotic agent with a distinctive research use beyond receptor pharmacology: enhancing macrophage clearance of apoptotic and lipid-laden cells. This guide connects practical efferocytosis workflows with schizophrenia biology while keeping in vitro evidence, clinical context, and translational limitations clearly separated.

• Carbenoxolone disodium: Practical Lab Guide

  2026-08-31

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled cell- and tissue-based studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is best used as a mechanistic perturbation tool with matched vehicle and orthogonal controls, not as a selective in vivo efficacy probe or a basis for clinical interpretation.

• Protein A/G Magnetic Beads: Practical Workflow

  2026-08-31

  Protein A/G Magnetic Beads support Fc-directed antibody capture, purification, immunoprecipitation, co-immunoprecipitation, and chromatin workflows from complex biological samples. They should be used with compatible IgG antibodies and assay-validated lysis, wash, and elution conditions; the dossier does not establish performance for every antibody species, isotype, target, or non-IgG format.

7799 records 1/520 page Next 12345 下5页 Last page